• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS, INC. ANGIOVAC; CATHETER, CANNULA & TUBING, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS, INC. ANGIOVAC; CATHETER, CANNULA & TUBING, VASCULAR Back to Search Results
Catalog Number VTX-3022
Device Problem Occlusion Within Device (1423)
Patient Problem Pulmonary Embolism (1498)
Event Date 03/21/2014
Event Type  Injury  
Event Description
With an 18f return arterial cannula placed in the right femoral sheath, the angiovac cannula was place in the right ij sheath over an 0.035 guidewire.Flow rates were initiated to 3 liters per min.When the flow rates dropped to zero, a ct image confirmed that a large undesirable intravascular material (uim) was occluding the cannula.The cannula was removed and a large uim was attached to the tip of the cannula.The cannula and the sheath were flushed and then re-introduced with flow rates of 3 liters achieved.Approximately 5-10 minutes after re-introduction of the cannula, the patient became hemodynamically unstable and cpr was initiated.The patient was put on ecmo support.A pa-gram was performed and revealed a pulmonary embolism in the rpa lower lobe.The patient was removed off ecmo on (b)(6) 2014 and a brain scan performed.She is recovering and has no adverse outcomes in regards to the angiovac procedure or cpr.No malfunction of the angiovac cannula or circuit was observed at any time by the clinical specialist or physician.The device is being retained by the hospital.
 
Manufacturer Narrative
Although it is not believed that the cause of the reported event is related to device malfunction, the investigation into this event is on-going, and will be including a review of the device history records for the reported lot.Upon completion of the investigation, a supplemental medwatch will be submitted.(b)(4).
 
Manufacturer Narrative
This medwatch was originally submitted under manufacturer report number: 3008075679-2014-00002.The manufacturer name has since changed from vortex medical to angiodynamics, and the manufacturer site registration number from 3008075679 to 2952363.The purpose of this supplemental form is to update the manufacturer report number from 3008075679-2014-00002 to 2952363-2014-00005.
 
Manufacturer Narrative
A review of the device history records was performed for the reported packaging lot for any deviations related to the reported defect of the complaint.The review confirms that the lot met all material, assembly and performance specifications.A review of the angiodynamics complaint report for the angiovac product family and the failure mode "patient injury" did not reveal any adverse trends.The end user hospital confirmed that there was no angiovac device malfunction during the procedure - device was not returned for evaluation.The patient's serious adverse event was related to anticipated procedural complications for removal of uim and the patient's medical condition.The angiovac cannula component is supplied to angiodynamics by the supplier duke emperical.Duke was been notified via supplier corrective action request for a device history records review of the supplier lot.Their response indicated that the od of the cannulas for the units released all meet the specification.All manufacturing records were completed and in order.There were no abnormalities that could have contributed to the reported event.The angiovac cannula sample was not returned for evaluation since there was no reported device failure.It cannot be determined if the cannula was used in accordance with its labeling.Directions for use are provided with this device and contains the following statements: adverse affects: this device, as do all extracorporeal blood vessel devices, has possible side effects, which include but are not limited to infections, blood loss, thrombus formation, embolic events, vessel damage and complications of percutaneous or surgical insertion techniques.These may occur if the instructions for use are not followed." (b)(4).Not returned to manufacturer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANGIOVAC
Type of Device
CATHETER, CANNULA & TUBING, VASCULAR
Manufacturer (Section D)
ANGIODYNAMICS, INC.
marlborough MA
Manufacturer (Section G)
ANGIODYNAMICS
26 forest street
marlborough MA 01752
Manufacturer Contact
law ryan
10 glens falls technical park
glens falls, NY 12801
5187424488
MDR Report Key3918076
MDR Text Key4584477
Report Number2952363-2014-00005
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092486
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/17/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVTX-3022
Device Lot Number106711-1
Other Device ID NumberANGIOVAC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/21/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age51 YR
Patient SexFemale
-
-